Cocrystal Pharma Inc reports results for the quarter ended in December - Earnings Summary

Cocrystal Pharma

23/03/2022 21:50

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 4 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 4 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 4 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had fallen by 10.8% this
quarter.
    * The company reported a quarterly loss of $3.69 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 23 at 09:49 p.m.  ​All
figures in US dollars unless otherwise stated